JEMO-PHARM A/S: Financial statements 2012
CVR: 10216109
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 10,956,649 and a net result of DKK 2,050,709. Equity in the 2012 report amounted to DKK 8,293,284. The solvency ratio was 34.5%.
- Gross Profit
- DKK 10,956,649
- Profit/Loss
- DKK 2,050,709
- Equity
- DKK 8,293,284
- Total Assets
- DKK 24,009,838
Official annual report
Keep an eye on JEMO-PHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of October 17, 2012, Svend Aage Dreist Hansen has joined the board of directors of JEMO-PHARM A/S.
As of October 17, 2012, Kaj Winther-Olsen has joined the board of directors of JEMO-PHARM A/S.
As of October 17, 2012, Henrik Winther Olsen has joined the board of directors of JEMO-PHARM A/S.
As of October 17, 2012, Peter Ejmund Samuelsen has left the board of directors of JEMO-PHARM A/S.
As of October 17, 2012, Henrik Winther Olsen is registered as director of JEMO-PHARM A/S.
As of October 17, 2012, Peter Ejmund Samuelsen has stepped down as adm. dir. of JEMO-PHARM A/S.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 27 employees (2018). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.